Q4 2025 Cresco Labs Inc Earnings Call Transcript
Key Points
- Cresco Labs Inc (CRLBF) reported $162 million in revenue for Q4 2025, with a strong adjusted gross profit of $84 million.
- The company achieved $40 million in adjusted EBITDA and $27 million in operating cash flow for the quarter.
- Cresco Labs Inc (CRLBF) strengthened its balance sheet by refinancing debt, extending maturities to 2030, and improving its capital structure.
- The company successfully exited the California market to focus on higher-return markets, enhancing financial flexibility.
- Cresco Labs Inc (CRLBF) maintained the number one branded market share in Illinois, Pennsylvania, and Massachusetts, showcasing strong retail and wholesale capabilities.
- Wholesale revenue declined approximately 6% quarter over quarter, reflecting a shift in strategy towards higher-margin channels.
- The company anticipates a high single-digit sequential decline in revenue for Q1 2026 due to Michigan's excise tax changes and the exit from California.
- Gross margin improvements in Q4 were partly due to favorable discrete items that may not repeat in future quarters.
- Cresco Labs Inc (CRLBF) took an impairment charge related to its New York operations, citing structural challenges in the market.
- The company faces ongoing price compression and competition in its core markets, impacting profitability.
Good day and welcome to Cresco Labs' fourth quarter 2025 earnings conference call. (Operator Instructions) Please note this event is being recorded. I'd now like to turn the call over to TJ Cole, Senior Vice President, Corporate Development and Investor Relations for Cresco Labs. Please go ahead, TJ.
Good morning and welcome to Cresco Labs' fourth quarter 2025 earnings conference call. On the call today, we have Chief Executive Officer and Co-Founder, Charles Boxtel, Chief Financial Officer, Sharon Shuler, and President, Greg Butler, who will be available for the Q&A. Prior to this call, we issue our fourth quarter earnings press release, which has been filed on CDAR and is available on our investor relations website. These preliminary results for the fourth quarter are provided prior to completion of all internal and external reviews and therefore are subject to adjustment to the filing of the company's quarterly and annual financial statements. We plan to file
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
